These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29369900)

  • 1. A Pattern-Based Approach Combining Tumor Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumors After Chemoradiotherapy.
    Lambregts DMJ; Delli Pizzi A; Lahaye MJ; van Griethuysen JJM; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
    Dis Colon Rectum; 2018 Mar; 61(3):328-337. PubMed ID: 29369900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.
    Liu S; Zhong GX; Zhou WX; Xue HD; Pan WD; Xu L; Lu JY; Wu B; Lin GL; Qiu HZ; Xiao Y
    Dis Colon Rectum; 2018 Aug; 61(8):903-910. PubMed ID: 29944579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.
    Lambregts DMJ; van Heeswijk MM; Delli Pizzi A; van Elderen SGC; Andrade L; Peters NHGM; Kint PAM; Osinga-de Jong M; Bipat S; Ooms R; Lahaye MJ; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
    Eur Radiol; 2017 Oct; 27(10):4445-4454. PubMed ID: 28409357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
    Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
    Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.
    Azamat S; Karaman Ş; Azamat IF; Ertaş G; Kulle CB; Keskin M; Sakin RND; Bakır B; Oral EN; Kartal MG
    Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
    Aker M; Ganeshan B; Afaq A; Wan S; Groves AM; Arulampalam T
    Dis Colon Rectum; 2019 Feb; 62(2):163-170. PubMed ID: 30451764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
    Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer.
    Gollub MJ; Blazic I; Felder S; Knezevic A; Gonen M; Garcia-Aguilar J; Paty PP; Smith JJ
    Eur Radiol; 2019 Mar; 29(3):1104-1113. PubMed ID: 30242504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term imaging characteristics of clinical complete responders during watch-and-wait for rectal cancer-an evaluation of over 1500 MRIs.
    Lambregts DMJ; Maas M; Boellaard TN; Delli Pizzi A; van der Sande ME; Hupkens BJP; Lahaye MJ; Bakers FCH; Beets GL; Beets-Tan RGH
    Eur Radiol; 2020 Jan; 30(1):272-280. PubMed ID: 31428827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of N0 Irradiated Rectal Cancer Comparing MRI Before and After Preoperative Chemoradiotherapy.
    Pomerri F; Crimì F; Veronese N; Perin A; Lacognata C; Bergamo F; Boso C; Maretto I
    Dis Colon Rectum; 2017 Nov; 60(11):1184-1191. PubMed ID: 28991083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
    Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
    Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response assessment after (chemo)radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?
    van der Sande ME; Beets GL; Hupkens BJ; Breukink SO; Melenhorst J; Bakers FC; Lambregts DM; Grabsch HI; Beets-Tan RG; Maas M
    Eur J Surg Oncol; 2019 Jun; 45(6):1011-1017. PubMed ID: 30528891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of FDG-PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer.
    Okuno T; Kawai K; Koyama K; Takahashi M; Ishihara S; Momose T; Morikawa T; Fukayama M; Watanabe T
    Dis Colon Rectum; 2018 Mar; 61(3):320-327. PubMed ID: 29360680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy.
    Horvat N; Veeraraghavan H; Khan M; Blazic I; Zheng J; Capanu M; Sala E; Garcia-Aguilar J; Gollub MJ; Petkovska I
    Radiology; 2018 Jun; 287(3):833-843. PubMed ID: 29514017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy.
    Lambregts DM; Maas M; Bakers FC; Cappendijk VC; Lammering G; Beets GL; Beets-Tan RG
    Dis Colon Rectum; 2011 Dec; 54(12):1521-8. PubMed ID: 22067180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader study.
    Bates DDB; Golia Pernicka JS; Fuqua JL; Paroder V; Petkovska I; Zheng J; Capanu M; Schilsky J; Gollub MJ
    Abdom Radiol (NY); 2020 Feb; 45(2):293-300. PubMed ID: 31690966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.